Glycosaminoglycan-interacting small molecule (gismo) as alzheimer's therapeutics
Ended Project Grant Awarded Last action
- Award ID
- R44AG056231
- Recipient
-
Gismo Therapeutics Inc. UEI SY29WJMD4E85
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,839,384
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- Kentucky, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $1,192,768 | |
| Amendment | $792,857 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $983,932 | |
| Amendment | $983,932 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $952,480 | |
| Original award | $933,415 |
Show all 15
Quick answers
Who received award R44AG056231?
R44AG056231 was awarded to Gismo Therapeutics Inc. by National Institute on Aging (National Institutes of Health) on September 1, 2017.
How much is award R44AG056231 worth?
$5,839,384 has been obligated on R44AG056231.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award